Certified by Founder Lodge
Lightstone Ventures
United States - Menlo Park, CA
INVESTOR
1 Disclosed Funding Rounds $37,900,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Lightstone Ventures is a global venture capital fund dedicated to translating novel scientific breakthroughs into clinically and commercially meaningful therapies. We invest in biotech and me
| Company | Date | Round | Raised |
|---|---|---|---|
Allay Therapeutics |
June, 06 ,2025 | Series D | $57,500,000 |
Relievant Medsystems, Inc. |
April, 21 ,2023 | Unknown | $50,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Alchemab Therapeutics Ltd |
September, 10 ,2025 | Series A | |
Cerevance |
April, 26 ,2024 | Series B | $47,000,000 |
Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
Allay Therapeutics |
June, 06 ,2025 | Series D | $57,500,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Alchemab Therapeutics Ltd |
September, 10 ,2025 | Series A | |
Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
Allay Therapeutics
Relievant Medsystems, Inc.
Apreo Health
Reprieve Cardiovascular
Alchemab Therapeutics Ltd
Cerevance
Crystalys Therapeutics
Atsena Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Tesoro XP, Inc. | $5,400,000 | (Jan 7, 2026)
dazzle ai | $8,000,000 | (Jan 7, 2026)
Truemed | $34,000,000 | (Jan 7, 2026)
Lucidean | $18,000,000 | (Jan 7, 2026)
Lemon Slice | $10,500,000 | (Jan 7, 2026)